Publications

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Authors: Ovarian Tumor Tissue Analysis (OTTA) Consortium, EL Goode, MS Block, KR Ka...

E-pub date: 1 Dec 2017

Journal name: JAMA Oncol

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.

Authors: L-A Martin, R Ribas, N Simigdala, E Schuster, S Pancholi, T Tenev, P Geller...

E-pub date: 30 Nov 2017

Journal name: Nat Commun

Synthesis and Multiple Incorporations of 2′-O-Methyl-5-hydroxymethylcytidine, 5-Hydroxymethylcytidine and 5-Formylcytidine Monomers into RNA Oligonucleotides.

Authors: AA Tanpure, S Balasubramanian

E-pub date: 16 Nov 2017

Journal name: Chembiochem

Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent.

Authors: B Xie, MR Tomaszewski, AA Neves, S Ros, D-E Hu, S McGuire, SR Mullins, D Ti...

E-pub date: 15 Nov 2017

Journal name: Clin Cancer Res

Machine learning model for sequence-driven DNA G-quadruplex formation.

Authors: AB Sahakyan, VS Chambers, G Marsico, T Santner, M Di Antonio, S Balasubrama...

E-pub date: 6 Nov 2017

Journal name: Sci Rep

Association analysis identifies 65 new breast cancer risk loci.

Authors: K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon,...

E-pub date: 2 Nov 2017

Journal name: Nature

Distance dependent photoacoustics revealed through DNA nanostructures.

Authors: J Joseph, KN Baumann, P Koehler, TJ Zuehlsdorff, DJ Cole, J Weber, SE Bohnd...

E-pub date: 2 Nov 2017

Journal name: Nanoscale

Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.

Authors: AM Oza, AV Tinker, A Oaknin, R Shapira-Frommer, IA McNeish, EM Swisher, I R...

E-pub date: 1 Nov 2017

Journal name: Gynecol Oncol

Filters

Research Groups

Core Facilities

Start date

End date

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.

Synthesis and Multiple Incorporations of 2′-O-Methyl-5-hydroxymethylcytidine, 5-Hydroxymethylcytidine and 5-Formylcytidine Monomers into RNA Oligonucleotides.

Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent.

Machine learning model for sequence-driven DNA G-quadruplex formation.

Association analysis identifies 65 new breast cancer risk loci.

Distance dependent photoacoustics revealed through DNA nanostructures.

Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.

Synthesis and Multiple Incorporations of 2′-O-Methyl-5-hydroxymethylcytidine, 5-Hydroxymethylcytidine and 5-Formylcytidine Monomers into RNA Oligonucleotides.

Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent.

Machine learning model for sequence-driven DNA G-quadruplex formation.

Association analysis identifies 65 new breast cancer risk loci.

Distance dependent photoacoustics revealed through DNA nanostructures.

Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.